...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents
【24h】

Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents

机译:以吲哚基部分为有效抗肿瘤剂的新型苯并噻唑衍生物的设计,合成,生物学评价和初步机理研究

获取原文
获取原文并翻译 | 示例

摘要

Through a structure-based molecular hybridization approach, a series of novel benzothiazole derivatives bearing indole-based moiety were designed, synthesized and screened for in vitro antitumor activity against four cancer cell lines (HT29, H460, A549 and MDA-MB-231). Most of them showed moderate to excellent activity against all the tested cell lines. Among them, compounds 20a-w with substituted benzyl-1H-indole moiety showed better selectivity against HT29 cancer cell line than other compounds. Compound 20d exhibited excellent antitumor activity with IC50 values of 0.024, 0.29, 0.84 and 0.88 mu M against HT29, H460, A549 and MDA-MB-231, respectively. Further mechanism studies indicated that the marked pharmacological activity of compound 20d might be ascribed to activation of procaspase-3 (apoptosis-inducing) and cell cycle arrest, which had emerged as a lead for further structural modifications. Furthermore, 3D-QSAR model (training set: q(2) = 0.850, r(2) = 0.987, test set: r(2) = 0.811) was built to provide a comprehensive guide for further structural modification and optimization. (C) 2015 Published by Elsevier Masson SAS.
机译:通过基于结构的分子杂交方法,设计,合成并筛选了一系列带有吲哚基部分的新型苯并噻唑衍生物,它们对四种癌细胞系(HT29,H460,A549和MDA-MB-231)具有体外抗肿瘤活性。它们中的大多数对所有测试的细胞系显示出中等至优异的活性。其中,具有取代的苄基-1H-吲哚部分的化合物20a-w显示出比其他化合物更好的针对HT29癌细胞系的选择性。化合物20d显示出优异的抗肿瘤活性,针对HT29,H460,A549和MDA-MB-231的IC 50值分别为0.024、0.29、0.84和0.88μM。进一步的机理研究表明,化合物20d的明显药理活性可能归因于procaspase-3的激活(诱导凋亡)和细胞周期停滞,这已成为进一步结构修饰的先导。此外,建立了3D-QSAR模型(​​训练集:q(2)= 0.850,r(2)= 0.987,测试集:r(2)= 0.811),为进一步的结构修改和优化提供了全面的指导。 (C)2015由Elsevier Masson SAS发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号